FDA 483 - Bachem Americas, Inc. - February 10, 2017

An FDA inspection of Bachem Americas, Inc. in Vista, CA, revealed two significant observations. The firm failed to implement appropriate controls over computer systems, specifically a titrator used for API moisture content, lacking validation and unauthorized data control. Additionally, a leaking plumbing system was observed near the manufacturing area, posing a contamination risk to drug products.